AzTrials
AzTrials

Implant ComplicationNCT04769934

Impact of Implant Insertion Torque on Peri-implant Bone Level.

An observational study of Implant Complication, run by University of Geneva, Switzerland at 1 site in Switzerland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Observational study with one single arm. The purpose of this study was to evaluate the impact of the insertion torque and of the implant stability on the marginal bone level changes for dental implants placed into healed ridges. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Implant Complication
What is being tested?
Penguin RFA
Type of treatment
Medical device
How many people
93 participants
Where
1 siteSwitzerland
Study dates
1 Aug 2018to 1 Aug 2021
How long will I take part?
3 Years
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: partially edentulous patients

Who may be able to join

  • All partially edentulous patients requiring simple Implant placement,
  • being at least 18-year-old and able to sign an informed consent,
  • The patients that will be enrolled must have a bone quantity that allows the placement of regular implants according to the radiographic evaluations (pre-operative radiographic examination).

Who cannot join

  • Heavy smokers (more than 10 cigarettes/day).
  • Immunosuppressed or immunocompromised patients
  • Uncontrolled diabetes
  • Active periodontal disease
  • Patients with a full mouth marginal bleeding score higher than 20%
  • Addiction to alcohol or drugs
Show all 12Show fewer
  • Psychiatric problems
  • Severe caries, periapical lesions, acute infection (abscess)
  • Immediate post-extractive implants (at least 2 months after extraction have to elapse)
  • Patients unable to commit to 3-year follow-up.
  • Patients treated or under treatment with intravenous amino- bisphosphonates.
  • Patients participating to other studies, if the present protocol could not be fully adhered to.

Trial locations and contacts

1 site in 1 country.

Irena Sailer, Prof. Dr. contact

+41 22 3794050

irena.sailer@unige.ch

Switzerland1 site, 1 recruiting
  • University of Geneva

    Geneva

    Irena Sailer, Prof. Dr., +41 22 3794050, irena.sailer@unige.ch

    Recruiting

Other trials in Switzerland

About this study

Observational study with one single arm. The purpose of this study was to evaluate the impact of the insertion torque and of the implant stability on the marginal bone level changes for dental implants placed into healed ridges.

Read the detailed description

The primary outcome would be to evaluate the peri-implant bone level changes (marginal bone level) around the implant platform.

The secondary outcomes would be:

  • To evaluate the Implant Stability Quotient (ISQ) changes according to the measurements performed with the instrument Penguin RFA
  • To evaluate the implant and prosthetic failure rate as well as the implant and prosthetic complication rates
  • The patient satisfaction related to the implant treatment
Being tested
Penguin RFA

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Penguin RFADevice

    to evaluate the peri-implant bone level changes (marginal bone level) around the implant platform.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. radiographic marginal bone level changes around the implant platform

    the changes (in mm) of the marginal bone level around the implant platform

    Measured: 3 years

Secondary outcomes (1)
  1. Implant Stability Quotient (ISQ) changes

    the measurements will be performed with the instrument Penguin RFA

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2021
  2. Study start1 Aug 2018
  3. Primary completion1 Aug 2021 (estimated)
  4. Study completion1 Aug 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
93 participants (estimated)
Target duration
3 Years
IDs, dates and publications
ClinicalTrials.gov ID
NCT04769934
Sponsor's protocol ID
2018-00666
Other IDs
2018
Status last verified
Feb 2021
First submitted
17 Feb 2021
Last updated
25 Feb 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Implant Complication, run by University of Geneva, Switzerland at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Irena Sailer, Prof. Dr. (+41 22 3794050, irena.sailer@unige.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

radiographic marginal bone level changes around the implant platform (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in